Discontinued — last reported Q1 '24
Eli Lilly Share Buybacks increased by 112.9% to $1.51B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 26.6%, from $2.05B to $1.51B. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 34.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Aggressive repurchases signal management's confidence that the stock is undervalued and a commitment to returning excess cash to investors.
The amount of cash spent to buy back the company's own shares from the open market. This is a key method of returning ca...
A critical metric for 'Big Tech' companies like Apple and Microsoft, which use massive cash flows to support share prices.
cf_share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $500.00M | $0.00 | $750.00M | $1.50B | $0.00 | $0.00 | $0.00 | $750.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $446.10M | $2.05B | $1.20B | $692.20M | $708.10M | $1.51B |
| QoQ Change | — | -100.0% | — | +100.0% | -100.0% | — | — | — | -100.0% | — | — | — | — | — | +360.4% | -41.6% | -42.3% | +2.3% | +112.9% |
| YoY Change | — | — | — | — | -100.0% | — | -100.0% | -50.0% | — | — | — | -100.0% | — | — | — | — | — | +58.7% | -26.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.